Title: Correlation between Transient Ischemic Left Ventricular Dilation and Severity of Coronary Artery Disease

Authors: Wala Abdelaziz Farid (MD), Ahmed Abdelaziz Emara (MD) , Mie Mohammed Abdalraouf (MD) , Mohamed Abd Al-Magid Mahmod, (MSc)

 DOI:  https://dx.doi.org/10.18535/jmscr/v6i2.83

Abstract

Background: Left ventricular (LV) transient ischemic dilatation (TID) during stress echocardiography is considered a marker of extensive coronary artery disease.

Objectives: To assess the relationship between (TID) ratio assessed by DSE and severity of CAD assessed by coronary angiography.

Methods: This study included 100 patients referred to stress echocardiography laboratory. All patients were subjected to detailed history, full cardiac examination, dobutamine stress echocardiography; The TID ratio was defined as the ratio of LV end-diastolic volume or end-systolic volume at post-stress to rest. MAPSE, was measured in (mm) by M. mode echocardiography from four different annuli in apical 4- and apical 2-chamber views . (Group I) (20) patients with normal findings, (group II) comprised (40) patients with abnormal ischemic stress echocardiography. These patients findings were further divided into two subgroups: Group (IIA): 40 patients with abnormal ischemic DSE without TID of the LV. Group (IIB): (40) patients with abnormal ischemic DSE with TID of the LV.

Results: A significant difference between group (IIA) and group (IIB) regarding ESV stress (P= 0.048) , EDV stress (P= 0.002). A highly significant difference between group (IIA) and group (IIB) regarding both the ESV ratio (P<0.001) and the EDV ratio (P<0.001). Also EDV ratio was statistically significant in group (IIB) regarding MAPSE at rest (P= 0.010) and stress (P=0.003). Also ESV ratio was statistically significant in group (IIB) regarding MAPSE at rest (P= 0.014) and stress (P=0.007).

Conclusion: Patients with TID have more sever and extensive ischemic defects and higher peak WMSI.

Keywords: Dobutamine stress echocardiography (DSE), Transient ischemic Dilation (TID), Mitral Annular Plane Systolic Excursion (MAPSE), Coronary artery disease (CAD).

References

  1. Rosa Sicari1 and Lauro Cortigiani :The clinical use of stress echocardiography in ischemic heart disease .Cardiovascular Ultrasound (2017) 15:7
  2. Sicari R, Nihoyannopoulos P, Evangelista A, European Association of Echocardio-graphy. Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr. 2008; 9:415-37.
  3. Picano E, Pellikka PA. Stress echo applications beyond coronary artery disease. Eur Heart J. 2013.
  4. Senior R and Chambers J.: Stress Echocardiography: Current Status. Br J Cardiol. 2007; 14(2):90-7.
  5. Carlson RE, Kavanaugh KM, Buda AJ: The effect of different mechanisms of myocardial ischemia on left ventricular function Am Heart J. 1988; 116:536-45.
  6. American Heart Association: International Cardiovascular Disease Statistics. Dallas, American Heart Association, 2004.
  7. Berthe C, Pierard LA, Hiernaux M.: Predicting the extent and location of coronary artery disease in acute myocardial infarction by echocardiography during dobutamine infusion. Am J Cardiol. 1986; 58: 1167-72.
  8. Mathias W Jr, Arruda A, Santos F, Arruda A. Safety of dobutamine-atropine stress echocardiography: a prospective experience of 4,033 consecutive studies. J Am SocEchocardiogr 1999;12:785-91.
  9. McLaughlin MG and Danias PG: Transient ischemic dilation: a powerful diagnostic and prognostic finding of stress myocardial perfusion imaging. J NuclCardiol. 2002; 9:663-7.
  10. Kurata C, Wakabayashi Y, Shouda S: Quantification of left ventricular size on exercise thallium-201 single-photon emission tomography. Eur J Nucl Med.1996; 23:762- 7.
  11. Heston TF and Sigg DM: Quantifying transient ischcmic dilation using gated SPECT. J NucliMed. 2005; 46:1990-6.
  12. Paul B, Kasliwa R;Dobutamine Stress Echocardiography - Methodology, Clinical Applications and Current Perspectives. J Assoc Physicians India. 2004; 52: 653-7.
  13. Hennessy TG, Codd MB, Kane G:  Dobutamine stress echocardiography in the detection of coronary artery disease: Importance of the pretest likelihood of disease. Am Heart J 1997;134:685–692.
  14. Carlsson M, Ugander M, Mosen H: Atrioventricular plane displacement is the major contributor to left ventricular pumping in healthy adults, athletes, and patients with dilated cardiomyopathy. Am J Physiol Heart CircPhysiol 2007; 292:H1452-9.
  15. Kotz S, Balakrishnan N, Read CB, Vidakovic B. Encyclopedia of statistical sciences. 2nd ed. Hoboken, N.J.: Wiley-Interscience; 2006.
  16. Carlhall C, Wigstrom L, Heiberg E: Contribu­tion of mitral annular excursion and shape dynamics to total left ventricular volume change. Am J Physiol Heart CircPhysiol 2004; 287: H1836-41.
  17. Claus P, Weidemann F, Dommke C: Mechan­isms of postsystolic thickening in ischemic myocardium: mathematical modelling and comparison with experimental ischemic substrates. Ultrasound Med Biol 2007; 33:1963-70.
  18. Kirkpatrick LA, Feeney BC. A simple guide to IBM SPSS statistics for version 20.0. Student ed. Belmont, Calif.: Wadsworth, Cengage Learning; 2013.
  19. Perlini S, Meyer TE, Foex P: Effects of preload, afterload and inotropy on dynamics of ischemic segmental wall motion. J Am CollCardiol 1997;29:846–855.
  20. Yao S, Shah A, Bangalore S: Transient ischemic left ventricular cavity dilation is a significant predictor of severe and extensive coronary artery disease and adverse outcomc in patients undergoing stress echocardiography. J Am Soc Eehocardiogr. 2007; 20(4):352.
  21. Turakhia MP, McManus DD, Whooley MA: Increase in end-systolic volume after exercise independently predicts mortality in patients with coronary heart disease: Data from the Heart and Soul Study. Eur Heart J 2009;30:2478–2484.
  22. Ballo P, Quatrini I, Giacomin El: Circumferential versus lon­gitudinal systolic function in patients with hypertension: a nonlinear relation. J Am SocEchocardiogr 2007; 20:298-306.

Corresponding Author

Abd Al-Magid Mahmod

Address: Tantal - Gharbia, Egypt

Tel: 01003907167, Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Wala Abdelaziz Farid (MD)

Address: Tanta- Gharbia, Egypt

Tel: 01067840607, Email: This email address is being protected from spambots. You need JavaScript enabled to view it.